ArticleInternational ophthalmology2014
The use of Densiron-68™ as a perioperative surgical tool.
Article in International ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Agents such as Densiron-68™, with specific gravity slightly greater than that of water (1.06 g/cm(3)), have been developed to tamponade the inferior retina following retinal detachment repair procedures. The minimal force that would result from the sinking of such an agent in balanced saline solution is not considered sufficient to permit the use of Densiron-68™ as a surgical tool to displace subretinal fluid and stabilise the retina perioperatively. We report five cases where Densiron-68™ was instilled directly into a saline-filled eye with an unstable retinal detachment. The detachment was reduced and the Densiron-68™ left in situ. Four cases involved giant retinal tears and the fifth an inferior retinal detachment with no breaks identified. The injection of Densiron-68™ as a single manoeuvre to flatten the retina and to simultaneously provide postoperative tamponade was successfully used in these five patients. Six months after removal of Densiron-68™ the retina remained flat in all five cases. This previously unfamiliar technique provides an additional surgical option to gain control in cases of complicated retinal detachment with a mobile retina, especially if inferior tamponade is required.
Indexed as
Identifiers
23359134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.